Published in Mol Cell on December 11, 2009
Linear ubiquitination prevents inflammation and regulates immune signalling. Nature (2011) 4.85
IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat Rev Cancer (2010) 4.08
Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nat Rev Drug Discov (2010) 2.90
Direct, noncatalytic mechanism of IKK inhibition by A20. Mol Cell (2011) 2.32
Post-translational modifications in signal integration. Nat Struct Mol Biol (2010) 2.23
Survivin and IAP proteins in cell-death mechanisms. Biochem J (2010) 2.18
The spatial and temporal organization of ubiquitin networks. Nat Rev Mol Cell Biol (2011) 2.15
Molecular basis of NF-κB signaling. Annu Rev Biophys (2013) 2.03
Fluorescence-based sensors to monitor localization and functions of linear and K63-linked ubiquitin chains in cells. Mol Cell (2012) 1.94
NF-κB/Rel proteins and the humoral immune responses of Drosophila melanogaster. Curr Top Microbiol Immunol (2011) 1.45
Influenza A virus polymerase inhibits type I interferon induction by binding to interferon beta promoter stimulator 1. J Biol Chem (2010) 1.43
Apoptotic cell signaling in cancer progression and therapy. Integr Biol (Camb) (2011) 1.22
Molecular cell death platforms and assemblies. Curr Opin Cell Biol (2010) 1.20
Analysis of nuclear factor-κB (NF-κB) essential modulator (NEMO) binding to linear and lysine-linked ubiquitin chains and its role in the activation of NF-κB. J Biol Chem (2012) 1.20
Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2. Cell Death Differ (2011) 1.18
Structure and ubiquitination-dependent activation of TANK-binding kinase 1. Cell Rep (2013) 1.17
TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat Rev Rheumatol (2015) 1.10
TRAF7 protein promotes Lys-29-linked polyubiquitination of IkappaB kinase (IKKgamma)/NF-kappaB essential modulator (NEMO) and p65/RelA protein and represses NF-kappaB activation. J Biol Chem (2011) 1.05
IAPs: guardians of RIPK1. Cell Death Differ (2011) 1.03
SHARPIN is a key regulator of immune and inflammatory responses. J Cell Mol Med (2012) 0.99
The p38 MAPK Pathway in Rheumatoid Arthritis: A Sideways Look. Open Rheumatol J (2012) 0.99
Zfra is a small wizard in the mitochondrial apoptosis. Aging (Albany NY) (2010) 0.97
Neoalbaconol induces cell death through necroptosis by regulating RIPK-dependent autocrine TNFα and ROS production. Oncotarget (2015) 0.96
Characterizing the connectivity of poly-ubiquitin chains by selected reaction monitoring mass spectrometry. Mol Biosyst (2010) 0.94
Arc of a vicious circle: pathways activated by Mycobacterium tuberculosis that target the HIV-1 long terminal repeat. Am J Respir Cell Mol Biol (2011) 0.93
A protective strategy against hyperinflammatory responses requiring the nontranscriptional actions of GPS2. Mol Cell (2012) 0.90
Protein-protein interaction antagonists as novel inhibitors of non-canonical polyubiquitylation. PLoS One (2010) 0.89
Lack of TNF-α-induced MMP-9 production and abnormal E-cadherin redistribution associated with compromised fusion in MCP-1-null macrophages. Am J Pathol (2011) 0.88
IKKε-mediated tumorigenesis requires K63-linked polyubiquitination by a cIAP1/cIAP2/TRAF2 E3 ubiquitin ligase complex. Cell Rep (2013) 0.87
TRIM5α-Mediated Ubiquitin Chain Conjugation Is Required for Inhibition of HIV-1 Reverse Transcription and Capsid Destabilization. J Virol (2015) 0.83
Linear ubiquitination signals in adaptive immune responses. Immunol Rev (2015) 0.81
Honokiol suppresses TNF-α-induced neutrophil adhesion on cerebral endothelial cells by disrupting polyubiquitination and degradation of IκBα. Sci Rep (2016) 0.81
The non-structural (NS) gene segment of H9N2 influenza virus isolated from backyard poultry in Pakistan reveals strong genetic and functional similarities to the NS gene of highly pathogenic H5N1. Virulence (2013) 0.78
The cofilin phosphatase slingshot homolog 1 (SSH1) links NOD1 signaling to actin remodeling. PLoS Pathog (2014) 0.78
Inhibition of Ubc13-mediated ubiquitination by GPS2 regulates multiple stages of B cell development. J Biol Chem (2016) 0.75
Quantitative Phospho-proteomic Analysis of TNFα/NFκB Signaling Reveals a Role for RIPK1 Phosphorylation in Suppressing Necrotic Cell Death. Mol Cell Proteomics (2017) 0.75
Disruption of DNA repair in cancer cells by ubiquitination of a destabilising dimerization domain of nucleotide excision repair protein ERCC1. Oncotarget (2017) 0.75
The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell (2011) 4.43
IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat Rev Cancer (2010) 4.08
Degradation of DIAP1 by the N-end rule pathway is essential for regulating apoptosis. Nat Cell Biol (2003) 3.56
Treatment of atypical hemolytic uremic syndrome and thrombotic microangiopathies: a focus on eculizumab. Am J Kidney Dis (2012) 2.48
PIMS modulates immune tolerance by negatively regulating Drosophila innate immune signaling. Cell Host Microbe (2008) 2.48
Feasibility of postmortem device acquisition for potential reuse in underserved nations. Heart Rhythm (2011) 2.14
Drug-eluting balloon angioplasty for in-stent restenosis: a systematic review and meta-analysis of randomised controlled trials. Heart (2013) 2.09
IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis. Nat Cell Biol (2008) 1.97
The DIAP1 RING finger mediates ubiquitination of Dronc and is indispensable for regulating apoptosis. Nat Cell Biol (2002) 1.97
CARD-mediated autoinhibition of cIAP1's E3 ligase activity suppresses cell proliferation and migration. Mol Cell (2011) 1.78
The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials. JACC Cardiovasc Interv (2009) 1.75
Safety of pacemaker reuse: a meta-analysis with implications for underserved nations. Circ Arrhythm Electrophysiol (2011) 1.70
Myocardial reperfusion injury: looking beyond primary PCI. Eur Heart J (2013) 1.65
IAPs are functionally non-equivalent and regulate effector caspases through distinct mechanisms. Nat Cell Biol (2004) 1.64
A fluorescent reporter of caspase activity for live imaging. Proc Natl Acad Sci U S A (2008) 1.55
Determinants of preformed collateral vessels in the human heart without coronary artery disease. Cardiology (2011) 1.54
Inactivation of effector caspases through nondegradative polyubiquitylation. Mol Cell (2008) 1.51
Sudden cardiac arrest during acute coronary occlusion - who is at risk? Cardiology (2010) 1.48
The relative myocardial blood volume differentiates between hypertensive heart disease and athlete's heart in humans. Eur Heart J (2006) 1.45
Triple versus dual antiplatelet therapy in acute coronary syndromes: adding cilostazol to aspirin and clopidogrel? Cardiology (2013) 1.44
Oxidized low-density lipoprotein cholesterol and coronary artery disease. Cardiology (2011) 1.43
Radial versus femoral access for primary percutaneous coronary intervention: is there a preferred route to the heart? Heart (2011) 1.42
The quantification of absolute myocardial perfusion in humans by contrast echocardiography: algorithm and validation. J Am Coll Cardiol (2005) 1.41
Clinical use of temporary percutaneous left ventricular assist devices. Catheter Cardiovasc Interv (2011) 1.40
IAP-antagonists exhibit non-redundant modes of action through differential DIAP1 binding. EMBO J (2003) 1.38
Caspase-mediated cleavage, IAP binding, and ubiquitination: linking three mechanisms crucial for Drosophila NF-kappaB signaling. Mol Cell (2010) 1.36
Safety and efficacy of subcutaneous-only granulocyte-macrophage colony-stimulating factor for collateral growth promotion in patients with coronary artery disease. J Am Coll Cardiol (2005) 1.36
Frequent atrial premature beats predict paroxysmal atrial fibrillation in stroke patients: an opportunity for a new diagnostic strategy. Stroke (2007) 1.35
The Drosophila inhibitor of apoptosis protein DIAP2 functions in innate immunity and is essential to resist gram-negative bacterial infection. Mol Cell Biol (2006) 1.35
Two roles for the Drosophila IKK complex in the activation of Relish and the induction of antimicrobial peptide genes. Proc Natl Acad Sci U S A (2009) 1.30
Inhibitor of apoptosis proteins in Drosophila: gatekeepers of death. Apoptosis (2009) 1.25
The human coronary collateral circulation: development and clinical importance. Eur Heart J (2013) 1.23
Jafrac2 is an IAP antagonist that promotes cell death by liberating Dronc from DIAP1. EMBO J (2002) 1.23
Efficacy of cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials. EuroIntervention (2009) 1.20
Stroke prevention by percutaneous closure of patent foramen ovale: a systematic review and meta-analysis. Heart (2013) 1.19
Systematic in vivo RNAi analysis identifies IAPs as NEDD8-E3 ligases. Mol Cell (2010) 1.13
Ubiquitin-mediated regulation of apoptosis. Trends Cell Biol (2009) 1.11
DIAP2 functions as a mechanism-based regulator of drICE that contributes to the caspase activity threshold in living cells. J Cell Biol (2007) 1.04
Ubiquitylation of the initiator caspase DREDD is required for innate immune signalling. EMBO J (2012) 1.03
Coronary collateral growth by external counterpulsation: a randomised controlled trial. Heart (2009) 1.03
To fight or die - inhibitor of apoptosis proteins at the crossroad of innate immunity and death. Curr Opin Cell Biol (2010) 0.99
Inhibitor of apoptosis (IAP) proteins-modulators of cell death and inflammation. Cold Spring Harb Perspect Biol (2013) 0.98
Drosophila IAP1-mediated ubiquitylation controls activation of the initiator caspase DRONC independent of protein degradation. PLoS Genet (2011) 0.97
The coronary collateral circulation--clinical relevances and therapeutic options. Heart (2012) 0.95
Targeted radiosensitization by the Chk1 inhibitor SAR-020106. Int J Radiat Oncol Biol Phys (2012) 0.93
Coronary collateral flow in response to endurance exercise training. Eur J Cardiovasc Prev Rehabil (2007) 0.91
A comparison of abciximab and small-molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials. Circ Cardiovasc Interv (2009) 0.87
Attenuation of myocardial reperfusion injury in pigs by Mirococept, a membrane-targeted complement inhibitor derived from human CR1. Cardiovasc Res (2007) 0.86
Locally targeted cytoprotection with dextran sulfate attenuates experimental porcine myocardial ischaemia/reperfusion injury. Eur Heart J (2005) 0.82
Regarding "Risk-adjusted 30-day outcomes of carotid stenting and endarterectomy: results from the SVS Vascular Registry". J Vasc Surg (2009) 0.82
[Retroperitoneal fibrosis: a rare cause of postrenal kidney failure, no to be missed]. Rev Med Suisse (2009) 0.81
Prognostic relevance of coronary collateral function: confounded or causal relationship? Heart (2013) 0.81
Advances in the hospital management of patients following an out of hospital cardiac arrest. Heart (2012) 0.80
Clopidogrel and cardiac surgery: enemy or friend? Heart (2012) 0.80
Coronary collateral function in the transplanted heart: propensity score matching with coronary artery disease. Heart (2011) 0.80
IAP degradation: decisive blow or altruistic sacrifice? Trends Cell Biol (2002) 0.80
Addition of dextran sulfate to blood cardioplegia attenuates reperfusion injury in a porcine model of cardiopulmonary bypass. Eur J Cardiothorac Surg (2008) 0.80
Evaluation of multimeric tyrosine-O-sulfate as a cytoprotectant in an in vivo model of acute myocardial infarction in pigs. Cardiology (2012) 0.80
Drug eluting balloons for de novo coronary lesions - a systematic review and meta-analysis. BMC Med (2013) 0.79
Influence of gender of physicians and patients on guideline-recommended treatment of chronic heart failure in a cross-sectional study. Eur J Heart Fail (2009) 0.79
Predictors of clinical outcome in transfemoral TAVI: circumferential iliofemoral calcifications and manufacturer-derived recommendations. Anatol J Cardiol (2014) 0.78
Almanac 2013: Acute coronary syndromes. Acta Cardiol (2014) 0.78
Myocardial blood volume and coronary resistance during and after coronary angioplasty. Am J Physiol Heart Circ Physiol (2011) 0.78
Ubiquitin-mediated regulation of RhoGTPase signalling: IAPs and HACE1 enter the fray. EMBO J (2012) 0.78
Variable ECG signs of ischemia during controlled occlusion of the left and right coronary artery in humans. Am J Physiol Heart Circ Physiol (2006) 0.77
Instantaneous coronary collateral function during supine bicycle exercise. Eur Heart J (2010) 0.77
Plasma level of soluble Fas is an independent marker of cardiovascular disease in ESRD patients. Kidney Int (2003) 0.77
Early intensification and autologous stem cell transplantation in patients with systemic AL amyloidosis: a single-centre experience. Ann Hematol (2008) 0.77
The impact of modern noninvasive cardiac imaging on coronary intervention rates. J Interv Cardiol (2013) 0.77
Endothelial-cell-binding aptamer for coating of intracoronary stents. J Invasive Cardiol (2010) 0.77
Haemodynamically irrelevant pericardial effusion is associated with increased mortality in patients with chronic heart failure. Eur Heart J (2013) 0.76
Optimal aspirin dose in acute coronary syndromes: an emerging consensus. Future Cardiol (2014) 0.76
[Hypomagnesemia and proton pump inhibitors]. Rev Med Suisse (2012) 0.76
Endothelialization of sirolimus-eluting stents with slow and extended drug release in the porcine overstretch model. J Invasive Cardiol (2008) 0.76
Optimal duration of clopidogrel therapy: the shorter the longer? Eur Heart J (2012) 0.76
Patients with good collateralization may profit from cilostazol. Cardiology (2012) 0.76
The coronary collateral circulation--past, present and future. Curr Cardiol Rev (2014) 0.76
'Paradoxical' low-flow, low-gradient severe aortic valve stenosis: an entity with limited improvement following transcatheter aortic valve implantation. J Heart Valve Dis (2014) 0.76
Discharge after primary angioplasty at 24 h: feasible and safe or a step too far? Cardiology (2013) 0.76
Percutaneous Aortic Balloon Valvuloplasty and Intracardiac Adrenaline in Electromechanical Dissociation as Bridge to Transcatheter Aortic Valve Implantation. Medicine (Baltimore) (2015) 0.75
Who should treat coronary left main disease--a battle of the titans? Cardiology (2011) 0.75
Defining the optimal treatment for elderly patients: lessons from real-world data. J Invasive Cardiol (2009) 0.75
The coronary collateral circulation--clinical predictors. Anadolu Kardiyol Derg (2012) 0.75
Bleeding complications in percutaneous coronary interventions. Cardiology (2013) 0.75
Drug-eluting balloon for instent restenosis--the author's reply. Heart (2013) 0.75
Predicting peri-procedural myocardial infarction during PCI. Heart (2012) 0.75
Exercise training for refractory angina: improving the coronary collateral circulation. Cardiology (2012) 0.75
Coronary collaterals-too small to be eyeballed, too large to be meaningless. Am J Cardiol (2010) 0.75
Plasma sTWEAK and PTX3: New determinant tools of cardiovascular outcome also in patients with CKD. Clin J Am Soc Nephrol (2011) 0.75
[Retroperitoneal fibrosis, M. Ormond, periaoartitis, ...?]. Ther Umsch (2008) 0.75
Idiopathic retroperitoneal fibrosis revealed by renal colic. Saudi J Kidney Dis Transpl (2008) 0.75
Biliary stent migration as a cause of cardiac tamponade. J Cardiovasc Med (Hagerstown) (2013) 0.75
Conservative management of inferior vena cava cement spike after percutaneous vertebroplasty causes fatal cardiac tamponade. J Rheumatol (2014) 0.75
Is rosiglitazone as safe as BARI 2D and the reanalysis of RECORD imply? Cardiology (2013) 0.75
Cochrane Corner: is there a benefit of using intracoronary vasodilators in ST segment elevation myocardial infarction? Heart (2013) 0.75
Are cyclooxygenase-2-selective inhibitors safe for the kidneys? Joint Bone Spine (2003) 0.75
BMC Medicine editorial board members on open access publishing. BMC Med (2014) 0.75
Time-lapse imaging of necrosis. Methods Mol Biol (2013) 0.75
Intimal proliferation and restenosis in paclitaxel-eluting stents with aminoparylene as carrier substance in swines. J Invasive Cardiol (2009) 0.75